Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02637843
Other study ID # ACCESS-I
Secondary ID
Status Completed
Phase N/A
First received December 16, 2015
Last updated August 12, 2016
Start date December 2015
Est. completion date July 2016

Study information

Verified date August 2016
Source Aarhus University Hospital Skejby
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Interventional

Clinical Trial Summary

Coronary angiography (CAG) and possible angioplasty (Percutaneous Coronary Intervention = PCI) can be performed by access from the groin (a. femoralis), the wrist (a. radialis) or the elbow (a. brachialis). It is well established that there is less risk of bleeding complications when using a radial access. The smaller diameters of the vessels in the forearm, however, may result in increased risk of pain during CAG/PCI via a. radialis. This is associated with vascular spasm (spasm tendency). Ultimately this means that one may have to convert to access via a. femoralis.

To perform a CAG/PCI, a tube (a so-called sheath) has to be inserted in a. radialis. It is unclear whether the design of the sheaths can reduce the spasm tendency, thus reducing pain. Terumo has recently introduced a new kind of sheath, so-called Terumo Glide Slender Heath Coated (hereafter referred to as "Slender sheath"). This sheath is partly coated, partly made of a thinner material. "Slender sheath" thus has an outer diameter smaller than that of the sheath from traditional use (Terumo Radio Focus sheath, hereafter referred to as "Standard sheath"), although the inner diameter (lumen) is the same in the two sheaths. In turn, the "Slender sheath" is more fragile and far more expensive.

The purpose of the present study is to evaluate whether use of slender sheath compared with standard sheath is Associated with less pain and fewer complications following CAG/PCI.


Description:

Study design: Randomized study

Purposes: to investigate whether the use of "Slender sheath" is associated with less pain compared to use of "Standard Sheath" and less complications corresponding at the access site. Specific hypotheses:

1. Use of "Slender sheath" results in less pain related to CAG/PCI compared to use of "Standard sheath".

2. Use of "Slender sheath" is associated with fewer conversions to femoral access compared to use of "Standard sheath".

3. Use of "Slender sheath" is associated with less use of analgesic during the procedure compared to use of "Standard sheath".

4. Use of "Slender sheath" is associated with fewer cases of occlusion of a. radialis at discharge and post-examination compared to use of "Standard sheath".

Time Schedule The trial will run from December 2015 until a total number of 1000 patients are included. It is expected that the data collection and publication of the results will be completed within a year.

Endpoints

1. Pain related to the application of the sheath (Visual Analog Scale = VAS)

2. Maximal pain during CAG/PCI (VAS)

3. Frequency of conversions to femoral access

4. Use of analgesics (cumulative amount of mg Fentanyl given)

5. Use of sedatives (cumulative amount of mg Midazolam given)

6. Use of Verapamil (cumulative amount of mg given, used to reduce spasms)

7. Number of catheters used

8. Number of sheaths used (femoral and radial)

9. Occlusion of a. radialis at the time of discharge estimated by ultrasound of the artery

10. Occlusion of a. radialis after a month (Assumes that all patients with open vessels at discharge also have open vessels after a month. Only patients with occluded vessels at discharge will be offered a new ultrasound scan)


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date July 2016
Est. primary completion date July 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

- All patients scheduled for radial angiography or angioplasty

- Able to give written informed consent

Exclusion Criteria:

- Negative Barbaue test or Allens test

- Use of 8F catheters

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Slender Sheath
Comparing outcomes for two different sheaths used during radial CAG/PCI

Locations

Country Name City State
Denmark Department of cardiology, Aarhus University Hospital in Skejby Aarhus

Sponsors (1)

Lead Sponsor Collaborator
Aarhus University Hospital Skejby

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain during sheath insertion Maximal pain (Visual analogue scale) during sheath insertion 1-2 minutes during sheath insertion Yes
Primary Pain during the procedure Maximal pain (Visual analogue scale) during CAG/PCI 10 minutes to 2 hours (during CAG/PCI) Yes
Primary Proportion converted to femoral access Proportion of patients where the operator has to change to femoral access to complete the CAG/PCI 10 minutes to 2 hours (during CAG/PCI) No
Primary Use of analgesics, sedatives and verapamil during the procedure cumulative amount of analgesics, sedatives and verapamil during the procedure 10 minutes to 2 hours (during CAG/PCI) Yes
Primary Patency of a.radialis Ultrasound and reverse Barbaeu test is performed to test patency of a.radialis following CAG/PCI. If patency not documented at time of discharge the tests are repeated at one month. The artery is patent if normal Barbaue test and ultrasound without occlusion. Within one month of CAG/PCI Yes
Secondary Number of catheters used cumulative number of catheters used during the procedure 10 minutes to 2 hours (during CAG/PCI) No
Secondary Number of sheaths used cumulative number of sheaths used during the procedure 10 minutes to 2 hours (during CAG/PCI) No